Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

Prostate cancer is the most diagnosed cancer among men in the United States. While the majority of patients who undergo surgery (prostatectomy) will essentially be cured, about 30–40% men remain at risk for disease progression and recurrence. Currently, patients are deemed at risk by evaluation of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284255/
https://www.ncbi.nlm.nih.gov/pubmed/22371711
http://dx.doi.org/10.3389/fgene.2012.00023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284255/
https://www.ncbi.nlm.nih.gov/pubmed/22371711
http://dx.doi.org/10.3389/fgene.2012.00023

Ejemplares similares